Medicare Reverses Denial of Costly Treatment for Hepatitis C Patient
May 19, 2014
This article was reported by The Reporter.
The Reporter announced that Medicare has reversed its decision and will cover the cost of the expensive new drugs to treat an Arizona man with hepatitis C virus (HCV) infection. Medicare officials have stated that the new policy will be used for HCV patients whose doctors prescribe combined use of the two drugs if the patients meet the criteria presented in January by the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases. The guidelines recommend combined use of the two drugs for patients with advanced liver disease who were not cured by earlier drug treatments.View Full Article
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)